Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04744155 · ClinicalTrials.gov registry record · NA
Reducing Adolescent Pregnancy in the Emergency Department
A NA study of Contraception and Adolescent Behavior, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 2
- Study locations
NCT04744155: Completed NA study of Contraception and Adolescent Behavior, sponsored by Children's Mercy Hospital Kansas City.
NCT04744155 is a NA study of Contraception and Adolescent Behavior that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 37 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04744155, a NA study of Contraception and Adolescent Behavior, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
A multi-site randomized trial. Adolescents enrolled in this Clinical Trial will be enrolled into one of two arms. Adolescents in both arms will receive motivational interviewing enhanced counseling and a referral for follow up care. Those randomized in the Multi-level intervention arm will be offered immediate Emergency Department based contraception in addition to receiving a warm referral (providing help with scheduling follow-up care).
Primary Outcome
The intervention will be deemed feasible if the median score across all items is ≥ 3. Individual responses range from 1 to 5. Higher scores indicate greater feasibility using the investigator created Feasibility Assessment.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Standard of Care
- BEHAVIORAL Multi-Level Intervention
Study Locations (2)
Missouri
- Children's Mercy Hospital - Kansas City
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT04744155 record still lists
NCT04744155 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard of Care is the first listed.
NCT04744155 reports a single indexed study location in Missouri, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04744155 about?
NCT04744155 is a clinical study titled "Reducing Adolescent Pregnancy in the Emergency Department". A multi-site randomized trial. Adolescents enrolled in this Clinical Trial will be enrolled into one of two arms. Adolescents in both arms will receive motivational interviewing enhanced counseling and a referral for follow up care. Those randomized in the Multi-level intervention arm will be offere...
What is the current status of trial NCT04744155?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-05-12. Estimated completion is 2023-05-01.
What conditions does trial NCT04744155 study?
This clinical trial studies the following conditions: Contraception, Adolescent Behavior, Emergency Department.
What interventions are being tested in trial NCT04744155?
The interventions under investigation include: Enhanced Standard of Care (BEHAVIORAL), Multi-Level Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04744155?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04744155 being conducted?
This trial has 2 study locations across Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04744155's enrollment target sits among peer trials
37 56th of 72 higher than 17 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI